MedPage Today) — In July 2024, Joseph Zucchi, PA-C, MPAS, wrote about how stigma and misconceptions were creating barriers to GLP-1 obesity medication uptake, on top of systemic barriers like high costs and inadequate insurance coverage. As part…
CMS Moved to Expand Obesity Drug Coverage. Private Insurers Need to Step Up.

Leave a Comment Leave a Comment